Your browser doesn't support javascript.
loading
Final results of a phase I radioimmunotherapy trial using (186)Re-epratuzumab for the treatment of patients with non-Hodgkin's lymphoma.
Postema, Ernst J; Raemaekers, John M M; Oyen, Wim J G; Boerman, Otto C; Mandigers, Caroline M P W; Goldenberg, David M; van Dongen, Guus A M S; Corstens, Frans H M.
Affiliation
  • Postema EJ; Department of Nuclear Medicine, University Medical Center Nijmegen, 6500 HB Nijmegen, the Netherlands. e.postema@nucmed.umcn.nl
Clin Cancer Res ; 9(10 Pt 2): 3995S-4002S, 2003 Sep 01.
Article in En | MEDLINE | ID: mdl-14506199
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Radioisotopes / Rhenium / Lymphoma, Non-Hodgkin / Cell Adhesion Molecules / Radioimmunotherapy / Antibodies, Monoclonal Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2003 Document type: Article Affiliation country: Países Bajos Country of publication: Estados Unidos
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Radioisotopes / Rhenium / Lymphoma, Non-Hodgkin / Cell Adhesion Molecules / Radioimmunotherapy / Antibodies, Monoclonal Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2003 Document type: Article Affiliation country: Países Bajos Country of publication: Estados Unidos